首页> 外文期刊>European urology >To what extent can we predict prostate cancer lymph node involvement?
【24h】

To what extent can we predict prostate cancer lymph node involvement?

机译:我们可以在多大程度上预测前列腺癌淋巴结受累?

获取原文
获取原文并翻译 | 示例
           

摘要

In this issue of European Urology, Godoy et al from the Memorial Sloan-Kettering Cancer Center (MSKCC) validate a previously developed preoperative nomogram to predict lymph node involvement (LNI) of prostate cancer at pelvic lymph node dissection (PLND) during radical prostatectomy (RP) [1 ]. These earlier data were derived from six institutions between 1985 and 2000 [2] and consisted of >5000 men, as opposed to the current study data, which are exclusively from MSKCC during 2000-2008 and include >3000 men. The accuracy of the original nomogram was 76% (area under the curve [AUC]: 0.76) compared to a level of 74% (AUC: 0.74) using the Partin tables [2], Both models use prostate-specific antigen (PSA), biopsy Gleason score, and clinical T stage.
机译:在本期《欧洲泌尿外科》上,纪念斯隆-凯特琳癌症中心(MSKCC)的Godoy等人验证了先前开发的术前列线图,以预测前列腺癌根治性切除术期间盆腔淋巴结清扫术(PLND)中前列腺癌的淋巴结受累(LNI)( RP)[1]。这些较早的数据来自1985年至2000年之间的六个机构[2],由> 5000人组成,而当前的研究数据仅来自2000-2008年期间的MSKCC,其中包括> 3000人。原始列线图的准确性为76%(曲线下的面积[AUC]:0.76),而使用Partin表[2]的准确性为74%(AUC:0.74),两个模型均使用前列腺特异性抗原(PSA) ,活检格里森评分和临床T期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号